Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 9 (HMGN2P9)

Target: HMGN2P9
Molecular classification: Pseudogene, Other (noncoding RNA locus)

Overview

High mobility group nucleosomal binding domain 2 pseudogene 9 (HMGN2P9) is a processed pseudogene found on chromosome 22 in humans. It does not encode a protein, and there is no evidence that it functions directly as a receptor, enzyme, transporter, or other classical therapeutic target[1][3][7]. Like other pseudogenes, HMGN2P9 may potentially influence gene expression indirectly through noncoding RNA mechanisms such as acting as a miRNA sink, participating in RNA interference, or competing for regulatory factors, but these roles have not been demonstrated for HMGN2P9 specifically[5][8]. Its common aliases include HMG17L1, HMGN2L9, dJ388M5, and dJ388M5.2[1][2][3][6].

Other names: HMG17L1HMGN2L9dJ388M5dJ388M5.2

Mechanism of action

Not applicable (no known function, protein, or interaction)

Biological functions

None (no protein product; not a functional gene)Potential regulatory role as noncoding RNA (general to pseudogenes, not specifically validated for HMGN2P9)May act as a miRNA sink or participate in gene regulation (general pseudogene function)

Disease associations

None known (no disease association reported for HMGN2P9 itself)General pseudogene function: Some pseudogenes have been linked to regulation in cancer, diabetes, etc., but no evidence for HMGN2P9 specifically

Safety considerations

None known (pseudogene, not used therapeutically)

Interacting drugs

None known or reported

Biomarkers

None known

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 9 (HMGN2P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 9 (HMGN2P9).

Explore the full profile